Discover the Power of Data with TICKR-BIO
Leading the Way in Predictive Analytics and Risk Assessment
OZMOSI brings over 20 years of expertise in delivering predictive analytics, risk assessments, and valuation models for the biopharmaceutical industry. Deep understanding of the marketplace and proprietary data drive our innovative approach to tracking changes in and making predictions about today’s rapidly evolving biopharma landscape.
Killer Data at Your Fingertips
Whether highlighting critical dates or identifying market-moving events, TICKR-BIO equips you with tools to make data-driven decisions and achieve higher returns. Our platform assembles critical clinical outcome information that can provide clarity and confidence in your investment decisions based on the potential future value of pharmaceutical and biotech products.
Unmatched Volatility Model
TICKR-BIO’s proprietary volatility model is second to none. Developed using data from decades of point-in-time clinical trial data, our model predicts potential volatility from catalyst events such as clinical trial outcomes. Our system is continuously scanning biopharma industry news and extracting upcoming clinical outcome announcements. We enhance this information with data about the product, the catalyst event, and the clinical trial landscape.
At the heart of our volatility model for catalyst events is best-in-class alternative data about the assets that have pending catalyst dates. Our PRYZM database aggregates all pertinent product information, the full clinical trial history, and the latest news. We know if the product in question has been approved for another indication or if another similar product for the same biological target has been approved. We are continuously tracking and cleaning the relevant disease areas, clinical trial phases, and latest product information for our catalyst event calendar and volatility model.
Helpful categories of data that feed our volatility model are the biological target, product modality, and potential impact on the company’s portfolio.
Biological Targets and Modalities
Biological targets are specific molecules or structures within the body that drugs interact with to produce desired effects. These targets include proteins, nucleic acids, receptors, pathogen components, and cell structures. Understanding these targets ensures specificity, efficacy, and biomarker identification, which are central to developing precise and effective biopharmaceutical treatments.
In the biopharma industry, modality refers to the type or method of treatment used to address a medical condition. Examples of modalities include small molecules, biologics, antibody-drug conjugates (ADCs), cell therapy, gene therapy, RNA-based therapies, peptide therapies, vaccines, and radiopharmaceuticals. Each of these modalities represents a unique approach to treating diseases, which reflects the diverse and innovative landscape of modern biopharma R&D.
Portfolio Impact Index
Our proprietary Portfolio Impact Index quantifies the value of a product in clinical development based on its impact on the company’s overall R&D portfolio. A higher Portfolio Value Index score indicates that a product has a greater impact on the company’s potential future growth, emphasizing the significance of catalyst events associated with the product.
Continuous Model Validation and Improvement
TICKR-BIO’s volatility prediction model uses this unparalleled wealth of alternative data to predict the stock price impact of catalyst events. Our model has demonstrated impressive accuracy to date, correctly predicting price volatility for 2 out of 3 reported events. We aren’t done yet, however. Our goal is to continuously improve the volatility model so it can provide investors with the most reliable information available to cut through the noise of the biopharma marketplace and help them make more informed decisions.
At TICKR-BIO we are committed to transparency. We will post regularly on actual results against our volatility predictions, ensuring that you stay informed and confident in your investment strategies. Discover the power of TICKR-BIO and take your investment decisions to the next level.